| Monday, May 04, 2009 |
| 2:30:00 PM |
Michael Shen, PhD |
Bldg 549 Auditorium |
| |
CANCELLED-Progenitor Cells of the Prostate Epithelium
|
Details
Series
|
| Tuesday, May 05, 2009 |
| 8:00:00 AM |
Harvey I. Pass, MD |
Bldg 549 Conf. Rm B |
| |
Mesothelioma: Clinical Frustration Mandating Scientific Inquiry
|
Details
Series
|
| Wednesday, May 06, 2009 |
| 12:00:00 PM |
Larry Keefer |
Bldg 549 Auditorium |
| |
Nitric Oxide and Immune System Function
|
Details
Series
|
| Friday, May 08, 2009 |
| 2:00:00 PM |
Dianne Newton |
Bldg 549 Auditorium |
| |
Development of Novel Anti-Cancer Agents Within the Biological Testing Branch
|
Details
|
| Monday, May 11, 2009 |
| 3:00:00 PM |
Dr. Michael Summers |
Bldg 549 Auditorium |
| |
Insights into the Mechanism of Retroviral Genome Packaging and Assembly
|
Details
Series
|
| Tuesday, May 12, 2009 |
| 8:00:00 AM |
Alan D'Andrea, MD |
Bldg 549 Conf. Rm B |
| |
Targeting DNA Repair Pathways in Cancer Therapy
|
Details
Series
|
|
| 8:30:00 AM |
Various Speakers |
Bldg 549 Auditorium |
| |
RNA Nanobiology: The Emerging Role of RNA in Nanobiology and Drug Design
|
Details
|
|
| 12:30:00 PM |
|
Bldg 539 Library |
| |
(1) "Barriers to the Emergence of Inter-subtype HIV-1 Recombinants" Speaker: Andrea Galli, HIV DRP
(2) "Novel Tumor Suppressor Pdcd4 Inhibits Translation Initiation to Prevent Tumorigenesis and Invasion" Speaker: Arti Santhanam, LCP
|
Details
Series
|
| Wednesday, May 13, 2009 |
| 12:00:00 PM |
Lino Tessarollo |
Bldg 549 Auditorium |
| |
Neurotrophins: Growth Factors at the Cross Road of Neurodegeneration and Cancer
|
Details
Series
|
|
| 2:00:00 PM |
Alan D'Andrea, MD |
Bldg 549 Auditorium |
| |
Regulation of DNA Repair by the Ubiquitin-Proteasome Pathway
|
Details
Series
|
| Thursday, May 14, 2009 |
| 12:00:00 PM |
Dr. Steve Weiss |
Bldg 549 Auditorium |
| |
Proteolytic Regulation of the Tissue-Invasive Phenotype: Just How Similar Are Cancer Cells and Leukocytes?
|
Details
Series
|
|
| 2:00:00 PM |
Louis M. Staudt, MD, PhD |
Bldg 549 Auditorium |
| |
Molecular Diagnosis and Molecular Targets in Lymphoma
|
Details
Series
|
| Friday, May 15, 2009 |
| 12:00:00 PM |
Stefan Ambs, PhD |
Bldg 549 Auditorium |
| |
A Diagnostic microRNA Expression Signature in Human Prostate Tumors
|
Details
Series
|
| Monday, May 18, 2009 |
| 2:30:00 PM |
Yigong Shi |
Bldg 549 Auditorium |
| |
Protein Phosphatase 2A: New Insights Into An Old Paradigm
|
Details
Series
|
|
| 3:00:00 PM |
Andrew Fire, PhD |
Bldg 10 Masur |
| |
Tracking B Cell Diversity and Clonality in Human Immunity and Disease
|
Details
Series
|
| Wednesday, May 20, 2009 |
| 9:00:00 AM |
Anil Kumar Sood, MD, FACOG, FACS |
Bldg 549 Auditorium |
| |
Therapeutic Gene Silencing in vivo Using RNA Interference
|
Details
Series
|
|
| 12:00:00 PM |
Stephen Lockett |
Bldg 549 Auditorium |
| |
Quantitative Microscopy: The Biology You Can't See
|
Details
Series
|
| Thursday, May 21, 2009 |
| 11:00:00 AM |
|
Bldg 37, 4041 |
| |
(1) A Distinct Gene Expression Signature of Inducible Nitric Oxide Synthase in Estrogen Receptor-Negative Breast Tumors, Speaker: Stefan Ambs, PhD, MPH, Lab of Human Carcinogenesis
(2)The Chemical Biology of Nitric Oxide in Signaling in Breast Cancer, Speaker: David Wink, PhD, Radiation Biology
|
Details
Series
|
| Tuesday, May 26, 2009 |
| 8:00:00 AM |
Joseph R. Nevins, PhD |
Bldg 549 Conf. Rm B |
| |
Genomic Strategies for Personalized Cancer Therapy
|
Details
Series
|
|
| 12:30:00 PM |
TBA |
Bldg 549 Auditorium |
| |
TBA
|
Details
Series
|
| Wednesday, May 27, 2009 |
| 9:30:00 AM |
Iwao Ojima |
Bldg 549 Auditorium |
| |
Tumor-Targeting Chemotherapeutic Agents
|
Details
|
|
| 12:00:00 PM |
Victor Marquez |
Bldg 549 Auditorium |
| |
Highlights of Thirty-Two Years of Drug Design and Chemistry at the NCI
|
Details
Series
|
| Friday, May 29, 2009 |
| 10:00:00 AM |
Katerina Politi, PhD |
Bldg 549 Auditorium |
| |
Defining the Mechanisms of EGFR-dependent Lung Tumorigenesis
|
Details
|
|
| 12:00:00 PM |
Dr. Avi Ashkenazi |
Bldg 549 Auditorium |
| |
Targeting Cancer with Pro-apoptotic Receptor Agonists
|
Details
Series
|
|
